Microinjection of Dihydrotestosterone as a 5α-Reduced Metabolite of Testosterone into CA1 Region of Hippocampus Could Improve Spatial Learning in the Adult Male Rats

Document Type: Research article

Authors

1 Department of Physiology and Pharmacology, Pasteur Institute, Tehran, Iran. Department of Physiology, Faculty of Sciences, Tehran University, Tehran, Iran.

2 Department of Physiology and Pharmacology, Pasteur Institute, Tehran, Iran.

3 Department of Physiology, Faculty of Sciences, Tehran University, Tehran, Iran.

Abstract

 
   CA1 region of hippocampus has an important role in learning and memory. Previous reports have shown that androgens like testosterone and its metabolites are present in high concentration in CA1 region of hippocampus. Androgen receptors have also high density in this region. Therefore, it is suggested that neurohormones in CA1 have an important role in learning and memory. It is likely that testosterone exerts its effect via its metabolites, especially dihydrotestosterone (DHT), a 5α-reduced androgen. In this research, we conducted an experiment to assess the path of testosterone›s effectiveness on spatial learning and memory. Adult male rats were randomly divided into 4 groups and, bilaterally, cannulated into CA1 region of hippocampus. One week after the surgery, animals received DMSO 0.5 μL as a control group and different doses of dihydrotestosterone (DHT) (0.25, 0.5 and 1 µg/0.5 μL/side) 25-30 min before the training in spatial version of Morris Water Maze task. Training session contained two blocks which animals had to learn the position of hidden platform in 4 trials. On the test session (next day), rats performed a one-trial probe test and then a visible platform one. The results showed that escape latency and traveled distance were decreased significantly in DHT-treated (0.5 µg/0.5 μL/side) rats. This finding suggested that DHT may have improved the effect on acquisition of spatial learning and memory.

Keywords

Main Subjects


 

Introduction

   Several investigations, in humans and animals, have shown the influence of androgens on learning processess using different learning tasks. There are numerous reports indicating that testosterone (T) administration can impair rat performance in spatial water maze (1-6) and inhibitory avoidance tasks (7). While some investigators have shown that the androgens improve cognitive performance (8-11), others have not been able to demonstrate a significant difference between the intact and T-depleted or T-administered male rats with respect to the spatial learning and memory (12).

   Several previous findings also suggest that the metabolites of T may be responsible or mediate some of the effects on learning and memory. T is metabolized through the 5α-reductase enzyme to dihydrotestosterone (DHT), a nonaromatizable androgen. It was shown that T or DHT replacement in gonadectomized (GDX) rats could enhance cognitive performance (13, 14). However, DHT can be further metabolized through 3α-hydroxysteroid dehydrogenase (3α-HSD) to 5α-androstane, 17β-diol (3α-diol), which can also influence the cognitive performance. For example, in male rats, the administration of 3α-androstanediol (3α-diol) is more effective than T or DHT in improving conditioned place preference (15, 16) or, performance in spatial tasks (17), while limiting the formation of 3α-diol with a 3α-HSD inhibitor reduces the performance in the inhibitory avoidance task of intact or GDX, DHT-replaced rats compared to GDX controls (14). Although the administration of the nonaromatizable androgen, DHT, to young male rats enhances the inhibitory avoidance, it does not seem to improve the performance in the radial water maze of 22-month-old male rats (18). These data indicate that the metabolites of T may play an important role in mediating the cognition.

   The hippocampus is an important target for androgens and androgens may improve cognitive performance through their action in hippocampus. The inhibitory avoidance, water maze and Y-maze tasks, are dependent upon the integrity of the hippocampus (19) and are influenced with androgen milieu (13, 20, 21). It is also known that the T-administration in GDX rats increases the hippocampal neuronal excitability (22). T-administration in male or female rats has also been shown to increase dendritic spine density in the CA3 and CA1 regions of the dorsal hippocampus and improves spatial navigation in the water maze (20, 23).

   Moreover, all of the enzymes necessary for T metabolism (aromatase, 5α-reductase, and 3α-HSD) are located within the hippocampus (24-26) and T metabolites are readily formed in this region (24, 27, 28). These data further demonstrates that the hippocampus is a major target for T and/or its metabolites.

   The study was designed to assess the effect of pre-training injections of dihydrotestosterone into the CA1 region of hippocampus on Morris water maze (MWM) performance.

 

Experimental

   Male albino Wistar rats (220-250 g) obtained from the Pasteur Institute of Iran were used in this study. Rats were housed in large cages (five per cage) before the surgery and individually in small cages after the surgery at room temperature of (25 ± 2°C) and standard 12:12 h light-dark cycle with light on at 07:00. Food and water were available ad-lib. These animal experimentations were carried out in accordance with the recommendations from the Declaration of Helsinki and internationally accepted principles for the use of experimental animals.

 

Surgery

   Rats were anesthetized with Ketamine (100 mg/Kg IP) and xylazine (3 mg/Kg IP) and placed in a Stereotaxic instrument (Stoelting, USA). Bilateral guide cannulas were implanted in the right and left CA1 and were attached to the skull surface using dental cement and jewellers screws. Stereotaxic coordinates based on Paxinos and Watsons atlas of the rat brain were: anterior-posterior (AP), -3.8 mm from bregma; medial-lateral (ML), ± 2.2 mm from midline; and dorsal–ventral (DV), -2.7 mm from the skull surface.

 

Microinjection procedure

   Intracereberal injection was done through guide cannula (23-gauge) using an injection needle (30-gauge) connected by polyethylene tubing to a 0.5 μL Hamilton micro-syringes. The injection needle was inserted 0.3 mm beyond the tip of the cannula and a 0.05 μL of vehicle (dimethyl sulfoxide, DMSO) or a different dose of dihydrotestosterone (DHT) was injected into each side of CA1 region over 2 min; the needle was left in place for an additional 60 sec before it was slowly withdrawn.R ats were divided into 4 groups that received vehicle (DMSO) or different doses of dihydrotestosterone (0.25, 0.5 and 1 μg/0.5 μL/side) 30 min before the training in MWM.

 

Behavioral assessment

Apparatus

   The water maze is a black circular tank 136 cm in diameter and 60 cm in height. The tank was filled with water (20 ± 1°C) to a depth of 25 cm. The maze was located in a room containing many extra maze cues (e.g. bookshelves, refrigerator and poster). The maze was divided geographically into four quadrants [Northeast (NE), Northwest (NW), Southeast (SE), Southwest (SW)] with starting positions [North (N), South (S), West (W), East (E)] that were equally spaced around the perimeter of the tank. A hidden circular platform (diameter: 10 cm) was located in the center of the SW quadrant, submerged 1 cm below the surface of water. A video camera was mounted directly above the maze to record rat’s swimming path. A tracking system was used to measure the escape latency, traveled distance and swimming speed of each rat and also the percent of distance and the time in each quadrant.

 

Procedure

   All testings began at 8:00 and each rat received eight trials of two blocks per day. Each rat was placed in the water facing the wall of the tank at one of the four designated starting points and allowed to swim and find the hidden platform located in the SW quadrant of the maze on every trial. Starting points were varied in a quasi-random fashion so that in each block, the rat started from each location once and never started from the same place on any block. During each trial, each rat was given 90 sec to find the hidden platform. If it found the platform, it was allowed to remain on it for 30 sec. If it failed to find the platform within 90 sec, it was placed on platform for 30 sec. During the first day, the position of platform remained constant. On the next day, the platform was elevated above the water surface and placed in the SE quadrant; this assessed Visio-motor coordination toward a visible platform.

 

Histology

   Following the behavioral testing, animals were sacrificed via decapitation and their brains were removed. For the histological examination of cannula and needle placement in CA1 area (Figure 1), 100 μm thick section was taken, mounted on slides and stained with cresyl violet. The cannula track was examined for each rat. Only those animals whose cannulas were exactly placed in CA1 region (40rats) were used for data analysis.

 

Figure 1. Nissl-stained coronal brain section from cannulated and injected rats. Cannula (C) and injection position (I) are shown.

 

Experimental protocol

   The aim of this experiment was to assess the effect of pre-training injections of dihydrotestosterone into the CA1 region of hippocampus on MWM performance. Forty rats were divided into 4 groups (n = 10) and received vehicle (DMSO) or different doses of dihydrotestosterone (0.25, 0.5 and 1 μg/0.5 μL/side) 30 min before the training in MWM.

 

Statistical analysis

   Kolmogorov-Smirnov test was used to examine the distribution of the data. Data obtained over training days from hidden platform tests and visible platform were analyzed by t-test for comparison between two groups and one-way analysis of variance (ANOVA) followed by Tukey’s test for multiple comparisons. All results are shown as means ± SEM. In all statistical comparisons, p < 0.05 was used as the criterion for statistical significance.

 

Results and Discussion

The effect of dihydrotestosterone

Hidden platform trails (day 1)

    Figures 2A-2E depict the results obtained from the DHT injection and the group receiving DMSO (control). A significant difference was generally found in escape latency (F = 4.502, p = 0.0065) and traveled distances (F = 3.167, p = 0.0308) between the groups (Figure 2A and 2B). No significant difference was found in swimming speed (F = 0.3864, p = 0.7632) between groups (Figure 2C).

   The differences in escape latency of block one (t = 3.227, p = 0.006) and block two (t = 2.573, p = 0.0221) and also differences in traveled distances of block one (t = 2.714, p = 0.0168) between the 0.5 μg group and control group were significantly different, but differences in traveled distances of block two (t = 2.039, p = 0.0608) were not significant (Figure 2D and 2E). This result suggests that the 0.5 μg group performed better than the control group over the training. Post-hoc multiple comparisons showed that the rats treated with 0.5 μg DHT dose had significantly improved in acquisition of spatial learning compared to the control rats.

 

Figure 2. Comparison of (A) escape latency, (B) traveled distance and (C) swimming speed across training day within different groups. **p < 0.01 and *p < 0.05 indicate significant difference vs. control (DMSO). Comparison of (D) escape latency and (E) traveled distance during each block of training day between 0.5 μg/0.5μL dihydrotestosterone treated group and the control group. **p < 0.01 and *p < 0.05 indicate the difference between each block and its respective block in control group.

 

Probe test (day 2)

   The results of probe test are shown in Figures 3A and 3B. One-way ANOVA did not reveal significant differences between the groups in escape latency (F = 0.2027; p = 0.8936) and traveled distances (F = 0.2694, p = 0.8469). The time and distance percentage that the animals spent at target quadrant was not significantly different in various groups. These results indicated that the CA1 region injection of DHT before the training was not effective in retention of memory after 24 h.

 

 

Figure 3. Comparison of (A) escape latency and (B) traveled distance during visible platform test. There were no significant differences between groups.

  

Visible platform trials (day 2)

   There was no significant difference in performance among the groups on the visible platform day for escape latency (F = 0.9114, p = 0.4481) or for traveled distance (F = 1.036, p = 0.3920) (Figure 4A and 4B).

 

Figure 4. Comparison of (A) escape latency and (B) traveled distance during visible platform test. There were no significant differences between groups.

 

   In our study, adult male rats treated with different doses of dihydrotestosterone (DHT) displayed acquisition of memory improvements with a DHT dose of 0.5 μg/0.5 μL in the MWM task.

     Since there were no significant differences between the control and experimental groups with respect to the visible platform test, it can be inferred that the observed changes could not be attributed to the alterations of non-mnemonic factors such as motivational or sensory processes induced through the treatments.

   The results of this study, along with the previous reports, conflicting effects of androgens on cognition, suggest that the cognitive/hormone interactions are quite complex. There are many researches on the cognitive performance of DHT effects as 5α-reduced androgens. Gonadectomy (GDX) has been shown to decrease the cognitive performance of male rats (13, 29) while systemic DHT administration is effective at enhancing the cognition of GDX rats in a variety of learning tasks (16, 17, 29-33). GDX has also been shown to reduce plasma levels of DHT and decrease the testing-training crossover latencies in the inhibitory avoidance task but DHT-replacement via silastic capsules restores performance in the inhibitory avoidance task and DHT levels of GDX rats to that of control (14) and intrahippocampal administration of DHT enhances learning in the inhibitory avoidance task compared to GDX controls (34).

   Biomont et al. showed that DHT has no mnemonic effects on the improvement of working memory in the radial-arm maze water task in aged male rats (35).

    Regarding our research and others, there are some possible explanations for the improvement effect of DHT.

   First of all, there are many substrates where androgens may exert their effects to enhance cognitive performance. For instance, DHT binds with high affinity to androgen receptors (ARs) (15). DHT, like other androgens, can diffuse into the cell and bind with an intracellular cytosolic receptor, the androgen receptor (AR). This complex is then translocated to the cell nucleus where it activates the transcription of genes with androgen-responsive elements (ARE) in their promoters (36). Intrahippocampal administration of flutamide, an AR antagonist, can also reverse the beneficial cognitive-enhancing effects of DHT replacement in GDX male rats (37). Several reports suggest that in addition to the well-known traditional effects of androgens via the intracellular receptors (genomic receptors), there are nongenomic androgen receptors that have activational effects. These receptors maybe coupled to membrane ion channels and second messenger systems, which elicit the rapid and transient changes in neuronal excitability (22, 38, 39). Therefore, DHT as an androgen may also exert its mnemonic effects via genomic and nongenomic pathway.

   Second, DHT is metabolized through 3α-hydroxysteroid dehydrogenase (3α-HSD) to 5α-androstane, 3α, 17β-diol (3α-diol). It is shown that Systemic 3α-diol administrations are effective at the enhancing cognition of GDX rats (13, 16, 32). In Ovariectomized rats injection of T, DHT, or 5α -androstane-3α, 17 beta-diol (3α-Diol) also enhanced cognitive performance in Y maze, inhibitory avoidance and object recognition tasks (17). Hippocampally administration of T and/or its 5α-reduced metabolites, DHT and 3α-androstanediol (3alpha-diol), in the conditioned fear and inhibitory avoidance tasks in intact and gonadectomized (GDX) androgen-replaced rats, showed that androgens enhancing effects on learning may be mediated in part by actions of 5alpha-reduced metabolites in the hippocampus (29-31, 33). However, 3α-diol was consistently elevated in each of these groups (31).

   Systemic or intrahippocampal administration of 3α-diol increased the crossover latencies in inhibitory avoidance task and significantly, enhanced the cognitive performance as compared to the vehicle-administered in GDX rats (34). Furthermore, blocking the metabolism of DHT to 3α-diol through indomethacin decreased the cognitive enhancing effects of DHT in male rats (14). Therefore, it is suggested that the converting of DHT to 3α-diol could possibly explain the effect of DHT on learning and memory.

   Third, there are multiple possible substrates for 3α-diols’ actions. All of the androgen administration regimens employed decrease the function of GABAA receptors (GBRs) in the cortex and hippocampus suggesting that GBRs is a substrate for androgen action (33). While 3α-diol has a low affinity for ARs, it has been shown to bind to GBRs (36, 40, 41), which has also been localized to the hippocampus (42), with a high affinity. 3α-diol, which may have effects at GABAA receptors (GBRs) (36, 43) can enhance learning and memory independent of T and DHT (31). Therefore, the actions at GABAA receptors, for which the 3α-diol has a high affinity (36), may be important in mediating the androgens’ mnemonic effects.

    As for the fourth point, some studies have demonstrated that the androgens like DHT may have actions at N-methyl-D-aspartate receptors (NMDARs) (44), which have been localized to the hippocampus Yoneda (45). NMDA receptor subunits (NR1, NR2A and NR2B) are involved in learning and memory processes (37). DHT treatment increased the spine synapses and NMDA receptor binding in the CA1 stratum orients and radiatum of the adult male rats (46). It is also possible that 3α-diol acts at these other substrates, such as N-methyl-D-aspartate receptors or via signal transduction pathways (47-49).

    Another point to ponder is that the DHT’s effects to enhance the learning and memory may take place, in part, through its metabolism to 3α-diol, and its subsequent actions at estrogen receptor β (ERβ) in the hippocampus (12, 31, 43). Knocking down expressions of ERβ, were effective at decreasing learning and memory in 3α-diol replaced rats (34). It is important to note that, although there are several variants of ERβ expressed in the brain (50, 51) this research did not discern between these different types (34). Among these splice variants, ERβ1 is probably the only variant with sufficient abundance and affinity for estrogenic ligands to exert the important neural effects, although alterations in splicing following neural damage cannot yet be ruled out (52).

 

Acknowledgment

    This work was granted by Pasteur Institute of Iran. The authors would like to thank Professor Ghasem Larijani who edited the manuscript.

(1) Gouchie C and D Kimura. The relationship between testosterone levels and cognitive ability patterns. Psychoneuroendocrinology (1991) 4: 323-334.

(2) Goudsmit E, Van De Poll NE and Swaab DF. Testosterone fails to reverse spatial memory decline in aged rats and impairs retention in young and middle-aged animals. Behav. Neural Biol. (1990) 1: 6-20.

(3) Hampson E. Spatial cognition in humans: possible modulation by androgens and estrogens. J. Psychiatry Neurosci. (1995) 20: 397-404.

(4) Moradpour F, Naghdi N and Fathollahi Y. Anastrozole improved testosterone-induced impairment acquisition of spatial learning and memory in the hippocampal CA1 region in adult male rats. Behav. Brain Res. (2006) 175: 223-232.

(5) Naghdi N, Nafisy N and Majlessi N. The effects of intrahippocampal testosterone and flutamide on spatial localization in the Morris water maze. Brain Res. (2001) 897: 44-51.

(6) Naghdi N, Oryan S and Etemadi R. The study of spatial memory in adult male rats with injection of testosterone enanthate and flutamide into the basolateral nucleus of the amygdala in Morris water maze. Brain Res. (2003) 972: 1-8.

(7) Naghdi N and Asadollahi A. Genomic and nongenomic effects of intrahippocampal microinjection of testosterone on long-term memory in male adult rats. Behav. Brain Res. (2004) 153: 1-6.

(8) Janowsky JS, Oviatt SK and Orwoll ES. Testosterone influences spatial cognition in older men. Behav. Neurosci. (1994) 108: 325-332.

(9) Lund BC, Bever-Stille KA and Perry PJ. Testosterone and andropause: the feasibility of testosterone replacement therapy in elderly men. Pharmacotherapy (1999) 19: 951-956.

(10) Sternbach H. Age-associated testosterone decline in men: clinical issues for psychiatry. Am. J. Psychiatry (1998) 155: 1310-8.

(11) Tan RS. Memory loss as a reported symptom of andropause. Systems Biol. Reproductive Med. (2001) 47: 185-189.

(12) Naghdi N, Mohaddess G, Khamnei S and Arjomand M. No significant difference between intact and testosterone depleted or administrated male rats in spatial learning and memory. Iranian J. Pharm. Res. (2005) 1: 29-32.

(13) Frye CA and Seliga AM. Testosterone increases analgesia, anxiolysis, and cognitive performance of male rats. Cogn. Affect Behav. Neurosci. (2001) 1: 371-81.

(14) Frye CA, Edinger KL, Seliga AM and Wawrzycki JM. 5alpha-reduced androgens may have actions in the hippocampus to enhance cognitive performance of male rats. Psychoneuroendocrinology (2004) 29: 1019-27.

(15) Rosellini RA, Svare BB, Rhodes ME, Frye CA. The testosterone metabolite and neurosteroid 3α-androstanediol may mediate the effects of testosterone on conditioned place preference. Brain Res. Rev. (2001) 37: 162-171.

(16) Frye CA, Rhodes ME, Rosellini R and Svare B.The nucleus accumbens as a site of action for rewarding properties of testosterone and its 5α-reduced metabolites. Pharmacol. Biochem. Behav. (2002) 74: 119-127.

(17) Frye C and Lacey E. Posttraining androgens’ enhancement of cognitive performance is temporally distinct from androgens’ increases in affective behavior. Cogn. Affective Behav. Neurosci. (2001) 1: 172-182.

(18) Bimonte-Nelson HA, Singleton MS, Nelson ME, Eckman CB, Barber J, Scott TW and Granholm ACE .Testosterone, but not nonaromatizable dihydrotestosterone, improves working memory and alters nerve growth factor levels in aged male rats. Exp. Neurol. (2003) 181: 301-12.

(19) Bannerman DM, Deacon R.M J, Offen S, Friswell J,Grubb M and Rawlins JNP. Double dissociation of function with the hippocampus: spatial memory and hyponeophagia. Behav. Neurosci. (2002) 5: 884-901.

(20) Isgor C and Sengelaub DR. Effects of neonatal gonadal steroids on adult CA3 pyramidal neuron dendritic morphology and spatial memory in rats. J. Neurobiol. (2003) 55: 179-90.

(21) Kritzer MF, McLaughlin PJ, Smirlis T and Robinson JK. Gonadectomy impairs T-Maze acquisition in adult male rats. Hormones Behav. (2001) 39: 167-174.

(22) Smith MD, Jones LS and Wilson MA. Sex differences in hippocampal slice excitability: role of testosterone. Neuroscience (2002) 109: 517-530.

(23) Leranth C, Petnehazy O and MacLusky NJ. Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats. J. Neurosci. (2003) 23: 1588-92.

(24) Li X, Bertics PJ and Karavolas HJ. Regional distribution of cytosolic and particulate 5alpha-dihydroprogesterone 3alpha-hydroxysteroid oxidoreductases in female rat brain. J. Steroid Biochem. Mol. Biol. (1997) 60: 311-8.

(25) Jacobs EC, Arnold AP and Campagnoni AT. Developmental regulation of the distribution of aromatase- and estrogen-receptor- mRNA-expressing cells in the zebra finch brain. Dev Neurosci (1999) 21: 453-72.

(26) Ivanova T and Beyer C. Ontogenetic expression and sex differences of aromatase and estrogen receptor-alpha/beta mRNA in the mouse hippocampus. Cell Tissue Res. (2000) 300: 231-7.

(27) MacLusky NJ, Walters MJ, Clark AS and Toran-Allerand CD.Aromatase in the cerebral cortex, hippocampus, and mid-brain: ontogeny and developmental implications. Mol. Cell. Neurosci. (1994) 5: 691-698.

(28) Pelletier G, Luu-The V and Labrie F. Immunocytochemical localization of 5α-reductase in rat brain. Mol. Cell. Neurosci. (1994) 5: 394-399.

(29) Edinger KL, Lee B and Frye CA. Mnemonic effects of testosterone and its 5α-reduced metabolites in the conditioned fear and inhibitory avoidance tasks. Pharmacol. Biochem. Behav. (2004) 78: 559-568.

(30) Frye CA and Edinger KL. Testosterone›s metabolism in the hippocampus may mediate its anti-anxiety effects in male rats. Pharmacol. Biochem. Behav. (2004) 78: 473-481.

(31) Edinger KL and Frye CA. Testosterone›s analgesic, anxiolytic, and cognitive-enhancing effects may be due in part to actions of its 5alpha-reduced metabolites in the hippocampus. Behav. Neurosci. (2004) 118: 1352-64.

(32) Frye CA and McCormick CM. The neurosteroid, 3α-androstanediol, prevents inhibitory avoidance deficits and pyknotic cells in the granule layer of the dentate gyrus induced by adrenalectomy in rats. Brain Res. (2000) 855: 166-170.

(33) Rosellini RA, Svare BB, Rhodes ME and Frye CA. The testosterone metabolite and neurosteroid 3alpha-androstanediol may mediate the effects of testosterone on conditioned place preference. Psychoneuroendocrinology (2001) 26: 731-50.

(34) Edinger KL and Frye CA. Androgens› effects to enhance learning may be mediated in part through actions at estrogen receptor-beta in the hippocampus. Neurobiol. Learn. Memory (2007) 87: 78-85.

(35) Brown TJ, Adler GH, Sharma M, Hochberg RB and MacLusky NJ. Androgen treatment decreases estrogen receptor binding in the ventromedial nucleus of the rat brain: a quantitative in-vitro autoradiographic analysis. Molecul. Cell. Neurosci. (1994) 5: 549-555.

(36) Frye CA, Duncan JE, Basham M and Erskine MS. Behavioral effects of 3 alpha-androstanediol. II: Hypothalamic and preoptic area actions via a GABAergic mechanism. Behav. Brain Res. (1996) 79: 119-30.

(37) Edinger KL and Frye CA. Androgens› performance-enhancing effects in the inhibitory avoidance and water maze tasks may involve actions at intracellular androgen receptors in the dorsal hippocampus. Neurobiol. Learn. Mem. 2007 87: 201-8.

(38) Rupprecht R and Holsboer F. Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends in Neurosci. (1999) 22: 410-416.

(39) Morley P, F Whitfield JF, Vanderhyden BC, Tsang BKand and Schwartz JL. A new, nongenomic estrogen action: the rapid release of intracellular calcium. Endocrinology (1992) 131: 1305-12.

(40) Frye CA, McCormick CM, Coopersmith C and Erskine MS. Effects of paced and non-paced mating stimulation on plasma progesterone, 3 alpha-diol and corticosterone. Psychoneuroendocrinology (1996) 21: 431-9.

(41) Frye CA. Analgesic effects of the neurosteroid 3α-androstanediol. Brain Res. (1996) 709: 1-9.

(42) Collinson N, Kuenzi FM, Jarolimek W, Maubach KA, Cothliff R, Sur C, Smith A, Otu FM, Howell O, Atack JR, McKernan RM, Seabrook GR, Dawson GR, Whiting PJ and Rosahl TW. Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor. J. Neurosci. (2002) 22: 5572-80.

(43) Pak TR, Chung WC, Lund TD, Hinds LR, Clay CM and Handa RJ.The androgen metabolite, 5alpha-androstane-3beta, 17beta-diol, is a potent modulator of estrogen receptor-beta1-mediated gene transcription in neuronal cells. Endocrinology (2005) 146: 147-55.

(44) Kus L, Handa RJ, Hautman JM, Beitz AJ. Castration increases [125I]MK801 binding in the hippocampus of male rats. Brain Res. (1995) 683: 270-4.

(45) Yoneyama M, Kitayama T, Taniura H, Yoneda Y. Immunohistochemical detection by immersion fixation with Carnoy solution of particular non-N-methyl-d-aspartate receptor subunits in murine hippocampus. Neurochem. Int. (2004) 44: 413-422.

(46) Romeo RD, Staub D, Jasnow AM, Karatsoreos IN, Thornton JE and McEwen BS. Dihydrotestosterone increases hippocampal N-methyl-d-aspartate binding but does not affect choline acetyltransferase cell number in the forebrain or choline transporter levels in the CA1 region of adult male rats. Endocrinology (2005) 146: 2091-2097.

(47) Pouliot WA, Handa RJ and Beck SG. Androgen modulates N-methyl-D-aspartate-mediated depolarization in CA1 hippocampal pyramidal cells. Synapse (1996) 23: 10-9.

(48) Rhodes ME and Frye CA. Androgens in the hippocampus can alter, and be altered by, ictal activity. Pharmacol. Biochem. Behav. (2004) 78: 483-493.

(49) Rhodes ME, Harney JP and Frye CA. Gonadal, adrenal, and neuroactive steroids› role in ictal activity. Brain Res. (2004) 1000: 8-18.

(50) Hanstein B, Liu H, Yancisin MC and Brown M. Functional analysis of a novel estrogen receptor-beta isoform. Mol. Endocrinol. (1999) 13: 129-37.

(51) Petersen DN, Tkalcevic GT, Mansolf AL, Rivera-Gonzalez R and Brown TA. Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed in normal rat tissues. Endocrinology (1998) 139: 1082-92.

(52) Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S and Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA (1996) 93: 5925-30.